SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017987
Filing Date
2023-11-07
Accepted
2023-11-07 16:05:38
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20230930x10q.htm   iXBRL 10-Q 2365276
2 EX-10.1 rigl-20230930xex10d1.htm EX-10.1 265841
3 EX-10.2 rigl-20230930xex10d2.htm EX-10.2 49140
4 EX-31.1 rigl-20230930xex31d1.htm EX-31.1 15899
5 EX-31.2 rigl-20230930xex31d2.htm EX-31.2 16785
6 EX-32.1 rigl-20230930xex32d1.htm EX-32.1 9081
7 GRAPHIC rigl-20230930x10q004.jpg GRAPHIC 75969
8 GRAPHIC rigl-20230930xex10d1001.jpg GRAPHIC 685
  Complete submission text file 0001558370-23-017987.txt   8902150

Data Files

Seq Description Document Type Size
9 EX-101.SCH rigl-20230930.xsd EX-101.SCH 48790
10 EX-101.CAL rigl-20230930_cal.xml EX-101.CAL 51660
11 EX-101.DEF rigl-20230930_def.xml EX-101.DEF 208065
12 EX-101.LAB rigl-20230930_lab.xml EX-101.LAB 439890
13 EX-101.PRE rigl-20230930_pre.xml EX-101.PRE 320320
63 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20230930x10q_htm.xml XML 1484421
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 231383658
SIC: 2834 Pharmaceutical Preparations